The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $98.90

Today's change-0.36 -0.36%
Updated May 3 4:15 PM EDT. Delayed by at least 15 minutes.
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $98.90

Today's change-0.36 -0.36%
Updated May 3 4:15 PM EDT. Delayed by at least 15 minutes.

Abiomed Inc crosses below 20-day moving average

Abiomed Inc closed lower Tuesday, dropping (U.S.)$0.36 or 0.36% to (U.S.)$98.90 and crossing below its 20-day moving average. Shares have lost 3.07% over the last five days, but have gained 9.55% over the last year to date. This security has outperformed the S&P 500 by 57.17% during the last year.

Key company metrics

  • Open(U.S.) $101.06
  • Previous close(U.S.) $99.26
  • High(U.S.) $101.40
  • Low(U.S.) $96.39
  • Bid / Ask-- / --
  • YTD % change+9.55%
  • Volume1,641,109
  • Average volume (10-day)650,419
  • Average volume (1-month)797,264
  • Average volume (3-month)680,191
  • 52-week range(U.S.) $59.04 to (U.S.) $110.68
  • Beta1.14
  • Trailing P/E34.90×
  • P/E 1 year forward124.59×
  • Forward PEG4.53×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.83
Updated May 3 4:15 PM EDT. Delayed by at least 15 minutes.
S&P TSX1.14%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue86767368
Total other revenue--------
Total revenue86767368
Gross profit73646357
Total cost of revenue13121111
Total operating expense68645855
Selling / general / administrative42403735
Research & development14121010
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income17131512
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax17131512
Income after tax118999
Income tax, total756-87
Net income118999
Total adjustments to net income--------
Net income before extra. items118999
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items118999
Inc. avail. to common incl. extra. items118999
Diluted net income118999
Dilution adjustment--------
Diluted weighted average shares45454444
Diluted EPS excluding extraordinary itemsvalue per share0.230.170.202.23
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.230.170.202.23